TradeUP Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $44.30M |
|---|---|
| IPO Date | Jul 15, 2021 |
| CEO | Jianwei Li; Weiguang “James” Yang |
| Left Lead | US Tiger Securities |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 18 + 6 + 12 |
| IPO Sector | Technology ▶ |
| IPO Geography | Global |
| Target Company | Estrella Biopharma, Inc. |
| Deal Announced | Oct 3, 2022 |
| Deal Size, $M | $338.70M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 31, 2023 |
| Amendment Vote | Jul 17, 2023 |
| Closing Date | Sep 29, 2023 |
Formerly UPTD
ESLA
ESLAW
| Price | $1.00 |
|---|---|
| Last closing price | $1.01 |
| H/L, today | $1.05 / $1.11 |
| H/L, 52-week | $1.29 / $5.62 |
| Volume, today | 14,683 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.